期刊文献+

Hypercoagulability in cancer patients grouped by syndromes differentiated with the theory of abnormal hilit in traditional Uyghur medicine

Hypercoagulability in cancer patients grouped by syndromes differentiated with the theory of abnormal hilit in traditional Uyghur medicine
原文传递
导出
摘要 OBJECTIVE:To investigate the relationship in malignant-neoplasm patients of hypercoagulability between syndromes differentiated with the theory of abnormal hilit in traditional Uyghur medicine(TUM).METHODS:A total of 248 patients with malignant tumors were enrolled.Based on the theory of TUM they were divided into two groups:abnormal Savda and abnormal Non-Savda(including abnormal Khan,abnormal Sepra and abnormal Belghem types);fifty healthy volunteers were selected as controls.Platelet(PLT),prothrombin time(PT),plasma fibrinogen(FIB),thrombin time(TT),activated partial thromboplastin time(aPTT)and D-Dimer(D-D)were measured in both groups.RESULTS:Compared with the control and abnor-mal Non-Savda groups,in the abnormal Savda group the PLT count increased(P<0.05),the PT was lengthened(P<0.01),and the FIB significantly increased(P<0.01).D-Ds in the three groups were significantly different(P<0.05).No significant difference was found inTT and aPTT values(P>0.05).CONCLUSION:Hypercoagulability existed in patients with malignant tumors in the different types of TUM syndromes,especially in the abnormal Savda group;this was characterized by increased blood viscosity,platelet aggregation and thrombosis.D-D appears to be a significant predictor for the therapeutic effect of TUM in relation to malignant tumor therapies. OBJECTIVE: To investigate the relationship in ma- lignant-neoplasm patients of hypercoagulability between syndromes differentiated with the theory of abnormal hilit in traditional Uyghur medicine(TUM). METHODS: A total of 248 patients with malignant tumors were enrolled. Based on the theory of TUM they were divided into two groups: abnormal Sav- da and abnormal Non-Savda(including abnormal Khan, abnormal Sepra and abnormal Belghem types); fifty healthy volunteers were selected as controls. Platelet(PLT), prothrombin time(PT), plas- ma fibrinogen(FIB), thrombin time(TT), activated partial thromboplastin time(aPTT) and D-Dimer(D-D) were measured in both groups. RESULTS: Compared with the control and abnor-mal Non-Savda groups, in the abnormal Savda group the PLT count increased(P0.05), the PT was lengthened(P0.01), and the FIB significantly in- creased(P0.01). D-Ds in the three groups were sig- nificantly different(P0.05). No significant differ- ence was found inTT and aPTT values(P0.05). CONCLUSION: Hypercoagulability existed in pa- tients with malignant tumors in the different types of TUM syndromes, especially in the abnormal Sav- da group; this was characterized by increased blood viscosity, platelet aggregation and thrombo- sis. D-D appears to be a significant predictor for the therapeutic effect of TUM in relation to malignant tumor therapies.
出处 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2014年第1期30-33,共4页 中医杂志(英文版)
基金 Supported by the Special Program for Key Basic Research of the Ministry of Science and Technology,China(No.2011CB512004)
关键词 Neoplasms THROMBOPHILIA Body flu-ids Blood platelets Partial thromboplastin time Fi-brin fragment D Traditional Uyghur medicine 肿瘤患者 传统医药 维吾尔族 综合征 异常 状态 体液 鉴别
  • 相关文献

参考文献9

  • 1Zecchina G,Ghio P,Bosio S. Reactive thrombocytosis might contribute to chemotherapy-related thrombophilia in patients with lung cancer[J].Clin Lung Cancer,2007,(4):264-267.
  • 2Brockmann MA,Giese A,Mueller K. Preoperative thrombocytosis predicts poor survival in patients with glioblastoma[J].{H}Neuro-Oncology,2007,(3):335-342.
  • 3Akl EA,Rohilla S,Barba M. Antagonists for the long term treatment of venous thromboembolism in patients with cancer:a cochrane systematic review[J].{H}Journal of Experimental and Clinical Cancer Research,2008,(3):21.
  • 4Akl EA,Muti P,Schnemann HJ. Anticoagulation in patients with cancer an overview of reviews[J].{H}Polskie Archiwum Medycyny Wewnetrznej,2008,(4):183-193.
  • 5Upur H. Therapy of mizaj and Hilit in Uyghur medicine and modern study[M].Urumqi:Xinjiang Science and Technology Publishing House,2003.40-52.
  • 6Upur H,Yusup A. The new theory of abnormal savda hilit in Uyghur medicine[M].Urumqi:Xinjiang People's publishing House,2009.7-9.
  • 7Wumar Turhun. Diagnostics of Uyghur medicine[M].Urumqi:Xinjiang People's publishing House,2006.66-69.
  • 8Chorostowska-Wynimko J,Swiercz R,SkrzypczakJankun E. Plasminogen activator inhibitor type-1 mutants regulate angiogenes is of human umbilical and vascular endothelial cells[J].{H}Oncology Reports,2004,(6):1155-1162.
  • 9Ay C,Vormittag R,Dunkler D. D-dimer and prothromb in fragment 1 + 2 predict venous thromboembolism in patients with cancer:results from the vienna cancer and thrombosis study[J].{H}Clinical Oncology,2009,(25):4124-4129.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部